DEERFIELD, Ill., May 17, 2010 (BUSINESS WIRE) -- Baxter International Inc. announced today that a voluntary recall of all manufactured lots of HYLENEX recombinant (hyaluronidase human injection) has ...

SAN DIEGO, Aug. 31 /PRNewswire/ -- Halozyme Therapeutics, Inc. (Nasdaq: HALO) today announced the completion of its root cause investigation regarding HYLENEX manufacturing and has identified a ...

Baxter announced a voluntary recall of all lots of Hylenex recombinant (hyaluronidase human injection) as a precautionary measure due to instances of particulate matter observed in a limited number of ...

Company also lifted notice of breach on Baxter Healthcare, which is manufacturing the product. Halozyme Therapeutics says that it has identified a corrective action plan and regulatory strategy to ...

A urinary catheter is a hollow, partially flexible tube that collects urine from the bladder and leads to a drainage bag. They come in many sizes and types. Catheters may be necessary in cases when ...

Agreement includes $10 million upfront and a $20-million equity investment. Halozyme Therapeutics and Baxter Healthcare expanded their existing Hylenex recombinant (hyaluronidase human injection) ...